Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable

Authors :: Parellada, E.
Andrezina, R.
Milanova, V.
Glue, P.
Masiak, M.
Turner, M. St. John
Medori, R.
Gaebel, W.
Source :: Journal of Psychopharmacology. September 2005, Vol. 19 Issue 5, 5
Publication Year :: 2005
Abstract: Abstract The efficacy and safety of risperidone long-acting injectable (RLAI) was investigated in patients in the early phases of schizophrenia and schizoaffective disorders (≤ 3 years). Patients who required a [...]

Subjects :: Schizoaffective disorders -- Diagnosis -- Care and treatment
Schizophrenia -- Diagnosis -- Care and treatment
Pharmaceuticals and cosmetics industries
Psychology and mental health
Diagnosis
Care and treatment

Tools